Vivoryon Therapeutics N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
23 aug 2016 - 07:00
Statutaire naam
Vivoryon Therapeutics N.V.
Titel
Probiodrug AG to Publish First Half 2016 Results on 30 August 2016
Bericht
Probiodrug AG to Publish First Half 2016 Results on 30 August 2016
HALLE (SAALE), Germany, 23 August 2016 - Probiodrug AG (Euronext Amsterdam: PBD), a biopharmaceutical company developing novel therapeutic solutions to treat Alzheimer's disease (AD), will publish its results for the first six months of 2016 on Tuesday, August 30, 2016. The company will host a conference call, open to the public on August 30, 2016 at 15:00 Central European Summer Time (CEST).
Datum laatste update: 27 december 2025